SelectQuote, Inc. Form 8-K Summary
Business Context and Reporting Period
SelectQuote, Inc. furnished this Form 8-K on May 10, 2023, reporting financial results for the third quarter ended March 31, 2023. The filing includes a related earnings press release and investor presentation as Exhibits 99.1 and 99.2, respectively; those exhibits were not included in the provided filing text.
Financial Results and Key Metrics
- The provided filing text does not state revenue, net income or loss, cash flow, margins, debt, liquidity, or other financial metrics.
- The detailed results appear to be contained in Exhibit 99.1, which is referenced but not reproduced in the source text.
Material Changes Versus the Prior Comparable Period
The filing text does not provide quantitative or qualitative comparisons with the prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
- The company referenced notification to the New York Stock Exchange of its intent to cure a stock-price deficiency and any potential plans for doing so.
- Forward-looking statements are subject to risks and uncertainties, including the company’s ability to regain compliance with NYSE continued-listing standards within the applicable cure period and to maintain compliance thereafter.
- The filing directs investors to the risk factors in the company’s Form 10-K for the year ended June 30, 2022 and subsequent SEC filings.
- The press release and investor presentation were furnished under Items 2.02 and 7.01 and are not deemed filed for Section 18 liability purposes or incorporated by reference, except where expressly stated.
Important Facts for Investors to Verify
- Review Exhibit 99.1 for the complete third-quarter financial results and year-over-year comparisons.
- Review Exhibit 99.2 for management commentary, operating metrics, outlook, and any guidance.
- Verify the nature, cure period, and current status of the NYSE stock-price deficiency.
- Assess the company’s liquidity, debt obligations, cash burn, and ability to maintain NYSE listing compliance using the full earnings materials and subsequent filings.